Unity Biotechnology, Inc. Long-Term Debt, Maturity, Year Four

Unity Biotechnology, Inc. Long-Term Debt, Maturity, Year Four

Unity Biotechnology, Inc. had Long-Term Debt, Maturity, Year Four of $8.89 million as of 2020-12-31, per its 10-K filed 2021-03-23.

Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity

us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour · last filed 2021-03-23

• 2020-12-31: Long-Term Debt, Maturity, Year Four $8.89M.
• 2020-09-30: Long-Term Debt, Maturity, Year Four $8.89M.